Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells

The deoxycytidine analogue 2′,2′-difluoro-2′-deoxycytidine (dFdC, gemcitabine) is a potent radiosensitiser, but has limited efficacy in combination with radiotherapy in patients with pancreatic cancer due to acute toxicity. We investigated whether cyclopentenyl cytosine (CPEC), targetting the ‘de no...

Descripción completa

Detalles Bibliográficos
Autores principales: van Bree, C, Rodermond, H M, Leen, R, Medema, J P, van Kuilenburg, A B P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359636/
https://www.ncbi.nlm.nih.gov/pubmed/18349845
http://dx.doi.org/10.1038/sj.bjc.6604287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359636/
https://www.ncbi.nlm.nih.gov/pubmed/18349845
http://dx.doi.org/10.1038/sj.bjc.6604287

Ejemplares similares